David E. Goel Adaptive Biotechnologies Corp (ADPT) insider trading activity
David E. Goel is Director of Adaptive Biotechnologies Corp. Currently has a direct ownership of 1,504 shares of ADPT, which is worth approximately $7,986. The most recent transaction as insider was on Feb 15, 2021, when has been sold 1,504 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.5K
0%
3M change
0%
12M change
Total Value Held
$7,986
DEG
David E. Goel
Director
Waltham, MA